Skip to main
NHI

NHI Stock Forecast & Price Target

NHI Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 20%
Buy 60%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

National Health Investors Inc. has demonstrated a positive outlook driven by an increase in normalized Funds from Operations (NFFO) estimates, which have been raised to $4.80 per share for 2025, aligning closely with management's guidance range. The company is also projected to achieve a year-over-year growth in normalized FFO per share of 5.3% in 2025 and 4.8% in 2026, reflecting strong operational performance and an encouraging trajectory. Additionally, the company's revenue streams from diverse real estate investments and senior housing operations position it favorably within the market, further enhancing its financial prospects.

Bears say

National Health Investors Inc. faces a negative outlook primarily due to anticipated lower earnings growth over the next few years, which reflects the challenges associated with balancing acquisition activities against operator issues and transitions. The reliance on rental income and the potential for lower-than-expected rent resets, particularly from its NHC segment, further exacerbates financial risks. Additionally, concerns over deferred rent collections and the vulnerability of operators, especially in the context of potential future pandemics or outbreaks, contribute to the adverse financial projections for the company.

NHI has been analyzed by 5 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 60% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of National Health Investors and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About National Health Investors (NHI) Forecast

Analysts have given NHI a Buy based on their latest research and market trends.

According to 5 analysts, NHI has a Buy consensus rating as of Dec 25, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $86.80, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $86.80, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

National Health Investors (NHI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.